CoChat
Sign Up
Cited by 30

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update

Oeckl, Patrick, Steinacker, Petra, Feneberg, Emily, Otto, Markus·2016·Journal of Neurochemistry
DOI 10.1111/jnc.13669
Open this paper in CoChat — free account

Abstract

Frontotemporal lobar degeneration (FTLD) is a spectrum of rare neurodegenerative diseases with overlapping symptoms and neuropathology. It includes the behavioral variant of frontotemporal dementia (bv FTD), the semantic and non‐fluent variant of primary progressive aphasia (sv PPA and nfv PPA), FTD with motor neuron disease (FTD‐MND), progressive supranuclear palsy, and corticobasal syndrome. The diagnosis of the FTLD spectrum of diseases is based on clinical symptoms which hampers the differentiation of the diseases among each other and with other disorders that show a similar clinical appearance resulting in a high rate of misdiagnoses. This highlights the need for objective and selective measures in the diagnostic criteria and there is extensive research on neurochemical biomarkers in FTLD as one option to address this unmet clinical need. Here, we review the advances in CSF biomarker research in FTLD in the last 2 years with regard to the validation of previously suggested and identification of new biomarker candidates for the differential diagnosis of FTLD. image New biomarkers for frontotemporal lobar degeneration (FTLD) are urgently needed to support differential diagnosis within the disease spectrum and with related neurodegenerative diseases such as Alzheimer disease (AD). Here, we review the advances in cerebrospinal fluid biomarker research in FTLD and provide a list of promising candidate markers. This article is part of the Frontotemporal Dementia special issue.

Overview

Integrity signals

Registry

Crossref · 10.1111/jnc.13669

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 11 references

Research works printed but not linked: 82

  1. 10.3390/ijms160817565 · DOI
  2. 10.1016/j.neurobiolaging.2006.03.010 · DOI
  3. 10.3233/JAD-140240 · DOI
  4. Alexopoulos P., 2012, Interrelations between CSF soluble AβPPβ, amyloid‐β 1‐42, SORL1, and tau levels in Alzheimer's disease, J. Alzheimers Dis., 28, 543, 10.3233/JAD-2011-110983 · DOI
  5. Almeida M. R., 2014, Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort, Neurodegener. Dis., 13, 214, 10.1159/000352022 · DOI
  6. 10.1001/jamaneurol.2015.1449 · DOI
  7. 10.1016/j.jns.2015.09.022 · DOI
  8. 10.1016/S0140-6736(15)00461-4 · DOI · Paper page
  9. 10.1016/j.parkreldis.2011.08.012 · DOI
  10. 10.1016/j.expneurol.2014.06.001 · DOI
  11. 10.1016/j.biopsych.2013.08.017 · DOI
  12. 10.1038/sj.mp.4001967 · DOI
  13. 10.1007/s00702-006-0618-z · DOI
  14. 10.1159/000322370 · DOI
  15. 10.1159/000089137 · DOI
  16. 10.1159/000353280 · DOI
  17. 10.3109/21678421.2014.971812 · DOI · Paper page
  18. 10.1001/archneur.59.8.1267 · DOI
  19. 10.1111/bpa.12044 · DOI
  20. Constantinescu R., 2012, Cerebrospinal fluid biomarker candidates for parkinsonian disorders, Front. Neurol., 3, 187
  21. 10.1016/j.parkreldis.2009.07.007 · DOI
  22. 10.1002/mds.21507 · DOI · Paper page
  23. 10.1016/j.jalz.2014.12.006 · DOI
  24. 10.1007/s00702-015-1486-1 · DOI · Paper page
  25. 10.3233/JAD-2011-110515 · DOI
  26. 10.1212/01.wnl.0000325058.10218.fc · DOI
  27. 10.1016/j.neurobiolaging.2014.10.023 · DOI
  28. 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  29. 10.1001/archneurol.2012.1654 · DOI · Paper page
  30. 10.1001/archpsyc.61.1.95 · DOI · Paper page
  31. Harten A. C., 2011, Tau and p‐tau as CSF biomarkers in dementia: a meta‐analysis, Clin. Chem. Lab. Med., 49, 353, 10.1515/CCLM.2011.086 · DOI
  32. 10.3389/fneur.2015.00091 · DOI
  33. 10.1002/mds.870130116 · DOI
  34. 10.1016/S1353-8020(00)00083-3 · DOI
  35. 10.1016/j.jns.2010.10.009 · DOI
  36. 10.1212/01.wnl.0000436625.63650.27 · DOI · Paper page
  37. 10.1136/jnnp-2012-303326 · DOI · Paper page
  38. 10.1002/acn3.266 · DOI · Paper page
  39. 10.1159/000371704 · DOI
  40. 10.1097/WAD.0b013e3181610fea · DOI
  41. 10.3109/21678421.2014.884592 · DOI
  42. 10.1212/WNL.47.1.1 · DOI · Paper page
  43. 10.1212/WNL.0000000000001642 · DOI · Paper page
  44. 10.1136/jnnp-2014-309562 · DOI
  45. 10.1002/acn3.212 · DOI
  46. 10.1021/pr5006058 · DOI
  47. 10.1016/j.bbapap.2014.12.010 · DOI
  48. 10.3109/21678 · DOI
  49. 10.1002/mds.25589 · DOI
  50. Palumbo B., 2008, Cerebrospinal fluid neuron‐specific enolase: a further marker of Alzheimer's disease?, Funct. Neurol., 23, 93
  51. 10.3233/JAD-2012-121471 · DOI · Paper page
  52. 10.1002/mds.23670 · DOI
  53. 10.1212/WNL.0b013e318221ad47 · DOI
  54. 10.1212/WNL.54.12.2277 · DOI
  55. 10.1097/NEN.0b013e3181fc9aea · DOI
  56. 10.1136/jnnp.2005.066043 · DOI
  57. 10.2165/11533100-000000000-00000 · DOI
  58. 10.1093/brain/awr179 · DOI · Paper page
  59. 10.1007/s10072-011-0866-z · DOI
  60. 10.1002/acn3.290 · DOI · Paper page
  61. 10.1001/archneur.60.9.1209 · DOI
  62. Salza R., 2015, Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease, J. Alzheimers Dis., 44, 1253, 10.3233/JAD-142544 · DOI
  63. 10.3233/JAD-141122 · DOI
  64. 10.1001/jamaneurol.2013.114 · DOI
  65. 10.1002/ana.24052 · DOI · Paper page
  66. 10.3233/JAD-2010-101032 · DOI
  67. 10.2165/11640070-000000000-00000 · DOI · Paper page
  68. 10.1212/WNL.0000000000001015 · DOI · Paper page
  69. 10.1093/brain/awv181 · DOI
  70. 10.1136/jnnp.2010.207183 · DOI
  71. Steinacker P., 2016, Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients, J. Neurol. Neurosurg. Psychiatry, 87, 12
  72. 10.3233/JAD-141986 · DOI
  73. 10.3389/fneur.2015.00138 · DOI
  74. 10.1016/j.neuron.2014.07.041 · DOI
  75. 10.1136/jnnp-2013-305972 · DOI
  76. 10.1002/mds.22895 · DOI
  77. 10.1007/s00702-014-1226-y · DOI
  78. 10.1016/j.neurobiolaging.2014.12.010 · DOI
  79. 10.1083/jcb.200712039 · DOI
  80. 10.1016/S0140-6736(15)00462-6 · DOI
  81. 10.1002/ana.24552 · DOI
  82. 10.1093/brain/awp071 · DOI · Paper page

Cited by

Sorted by citations

See all 30

Metadata

Authors
Oeckl, P., Steinacker, P., Feneberg, E., & Otto, M.
Affiliations
Department of Neurology Ulm University Hospital Ulm Germany
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2016-06-15
Volume
138
Issue
S1
Pages
184-192
ISSN
  • 0022-3042
  • 1471-4159
DOI
10.1111/jnc.13669
Cited by
30
References
11
Language
en
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Funders
  • JPND networks SOPHIA (01ED1202A)
  • PreFrontAls (01ED1512)
  • BiomarkAPD (01ED1203F)
  • German Federal Ministry of Education and Research (FTLDc O1GI1007A, MND-Net 01GM1103A)
  • EU (NADINE 246513, FAIR-PARK II 633190)
  • the foundation of the state Baden-Württemberg (D.3830)
  • BIU (D.5009)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review